» Articles » PMID: 24302644

Effects of Stretch and Shortening on Gene Expression in Intact Myocardium

Overview
Date 2013 Dec 5
PMID 24302644
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple cues have been suggested as the mechanical stimulus for the heart's hypertrophic response. Our work has previously suggested that the amount of cyclic shortening in cardiomyocytes controls myocyte shape and the amount of stretch controls myocyte size. To identify gene expression changes that occur in response to these mechanical perturbations, we used microarray analysis of papillary muscles cultured for 12 h at physiological or reduced levels of cyclic shortening and physiological or reduced mean stretch. Overall, genes related to extracellular matrix (ECM) were surprisingly prominent in our analysis. Connective tissue growth factor was among a small group of genes regulated by the amount of cyclic shortening regardless of the level of mean stretch, and many more ECM genes were regulated by shortening with reduced amounts of stretch. When we compared our results to gene expression data from an in vivo model of pressure overload (PO), which also decreases myocyte shortening, we found the genes that were commonly regulated in PO and our decreased shortening groups were most significantly enriched for ontology terms related to the ECM, followed by genes associated with mechanosensing and the cytoskeleton. The list of genes regulated in PO and our decreased shortening groups also includes genes known to change early in hypertrophy, such as myosin heavy chain 7, brain natriuretic peptide, and myosin binding protein C. We conclude that in intact myocardium, the amount of cyclic shortening may be an important regulator not only of myocyte genes classically associated with hypertrophy but also of ECM genes.

Citing Articles

Toward Cardiac Regeneration: Combination of Pluripotent Stem Cell-Based Therapies and Bioengineering Strategies.

Mazzola M, Di Pasquale E Front Bioeng Biotechnol. 2020; 8:455.

PMID: 32528940 PMC: 7266938. DOI: 10.3389/fbioe.2020.00455.


Mechanical regulation of gene expression in cardiac myocytes and fibroblasts.

Saucerman J, Tan P, Buchholz K, McCulloch A, Omens J Nat Rev Cardiol. 2019; 16(6):361-378.

PMID: 30683889 PMC: 6525041. DOI: 10.1038/s41569-019-0155-8.


How does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na pumps are crucial.

Blaustein M Am J Physiol Heart Circ Physiol. 2017; 313(5):H919-H930.

PMID: 28733446 PMC: 5792198. DOI: 10.1152/ajpheart.00131.2017.


Electrical and mechanical stimulation of cardiac cells and tissue constructs.

Stoppel W, Kaplan D, Black 3rd L Adv Drug Deliv Rev. 2015; 96:135-55.

PMID: 26232525 PMC: 4698182. DOI: 10.1016/j.addr.2015.07.009.


Mechanotransduction Mechanisms for Intraventricular Diastolic Vortex Forces and Myocardial Deformations: Part 2.

Pasipoularides A J Cardiovasc Transl Res. 2015; 8(5):293-318.

PMID: 25971844 PMC: 4519381. DOI: 10.1007/s12265-015-9630-8.

References
1.
Baker B, Chen C . Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012; 125(Pt 13):3015-24. PMC: 3434846. DOI: 10.1242/jcs.079509. View

2.
Ling L, Enriquez-Sarano M, Seward J, Tajik A, Schaff H, Bailey K . Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996; 335(19):1417-23. DOI: 10.1056/NEJM199611073351902. View

3.
Gottdiener J, Arnold A, Aurigemma G, Polak J, Tracy R, Kitzman D . Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000; 35(6):1628-37. DOI: 10.1016/s0735-1097(00)00582-9. View

4.
Ruwhof C, van Wamel A, van der Valk L, Schrier P, van der Laarse A . Direct, autocrine and paracrine effects of cyclic stretch on growth of myocytes and fibroblasts isolated from neonatal rat ventricles. Arch Physiol Biochem. 2001; 109(1):10-7. DOI: 10.1076/apab.109.1.10.4285. View

5.
Modlich O, Prisack H, Munnes M, Audretsch W, Bojar H . Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease. Clin Cancer Res. 2004; 10(19):6418-31. DOI: 10.1158/1078-0432.CCR-04-1031. View